PON1 and mediterranean diet

Nutrients

Volumn 7, Issue 6, 2015, Pages 4068-4092

  Lou Bonafonte, José M ^a,b   Gabás Rivera, Clara ^a,b   Navarro, María A ^a,b   Osada, Jesús ^a,b  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Fruits; Mediterranean diet; Nutraceuticals; Nuts; Olive oil; Paraoxonase 1; PON1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE; CAROTENOID; OLIVE OIL; PHENOL DERIVATIVE; PON1 PROTEIN, HUMAN;

ANTIOXIDANT ACTIVITY; ARTICLE; CALORIC INTAKE; DIETARY COMPLIANCE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; MEDITERRANEAN DIET; NONHUMAN; NUTRIGENOMICS; NUTRITIONAL ASSESSMENT; OXIDATIVE STRESS; PROTEIN EXPRESSION; ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; DISEASE MODEL; FRUIT; METABOLISM; NUT; PROTEIN CONFORMATION; RISK FACTOR; VEGETABLE;

LYTHRACEAE;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CARDIOVASCULAR DISEASES; CAROTENOIDS; DIET, MEDITERRANEAN; DISEASE MODELS, ANIMAL; FRUIT; HUMANS; NUTS; OLIVE OIL; PHENOLS; PROTEIN CONFORMATION; RISK FACTORS; VEGETABLES;

EID: 84930958999     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7064068     Document Type: Article

References (139)

1. Deakin, S.; Leviev, I.; Gomaraschi, M.; Calabresi, L.; Franceschini, G.; James, R.W. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J. Biol. Chem.2002, 277, 4301–4308
2. Durrington, P.N.; Mackness, B.; Mackness, M.I. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol.2001, 21, 473–480
3. Rozenberg, O.; Rosenblat, M.; Coleman, R.; Shih, D.M.; Aviram, M. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice. Free Radic. Biol. Med.2003, 34, 774–784
4. Ferretti, G.; Bacchetti, T. Effect of dietary lipids on paraoxonase-1 activity and gene expression. Nutr. Metab. Cardiovasc. Dis.2012, 22, 88–94
5. Loued, S.; Isabelle, M.; Berrougui, H.; Khalil, A. The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins. Life Sci. 2012, 90, 82–88
6. Abbott, C.A.; Mackness, M.I.; Kumar, S.; Boulton, A.J.; Durrington, P.N. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc. Biol.1995, 15, 1812–1818
7. Seres, I.; Paragh, G.; Deschene, E.; Fulop, T., Jr.; Khalil, A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp. Gerontol.2004, 39, 59–66
8. Deakin, S.P.; James, R.W. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin. Sci. (Lond.)2004, 107, 435–447
9. Loued, S.; Berrougui, H.; Componova, P.; Ikhlef, S.; Helal, O.; Khalil, A. Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities. Br. J. Nutr.2013, 110, 1272–1284
10. Bub, A.; Barth, S.; Watzl, B.; Briviba, K.; Herbert, B.M.; Luhrmann, P.M.; Neuhauser-Berthold, M.; Rechkemmer, G. Paraoxonase 1 Q192R (PON1–192) polymorphism is associated with reduced lipid peroxidation in R-allele-carrier but not in QQ homozygous elderly subjects on a tomato-rich diet. Eur. J. Nutr.2002, 41, 237–243
11. Koubaa, N.; Nakbi, A.; Hammami, S.; Attia, N.; Mehri, S.; Ben Hamda, K.; Ben Farhat, M.; Miled, A.; Hammami, M. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome. Clin. Biochem.2009, 42, 771–776
12. Costa, L.G.; Vitalone, A.; Cole, T.B.; Furlong, C.E. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol.2005, 69, 541–550
13. Rajkovic, M.G.; Rumora, L.; Barisic, K. The paraoxonase 1, 2 and 3 in humans. Biochem. Med. (Zagreb)2011, 21, 122–130
14. Da Costa, L.A.; Badawi, A.; El-Sohemy, A. Nutrigenetics and modulation of oxidative stress. Ann. Nutr. Metab.2012, 60(Suppl. 3), 27–36
15. Durrington, P.N.; Mackness, B.; Mackness, M.I. The hunt for nutritional and pharmacological modulators of paraoxonase. Arterioscler. Thromb. Vasc. Biol.2002, 22, 1248–1250
16. Keys, A. Mediterranean diet and public health: Personal reflections. Am. J. Clin. Nutr. 1995, 61 (Suppl. 6), 1321S–1323S
17. Estruch, R.; Ros, E.; Salas-Salvado, J.; Covas, M.I.; Corella, D.; Aros, F.; Gomez-Gracia, E.; Ruiz-Gutierrez, V.; Fiol, M.; Lapetra, J.; et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med.2013, 368, 1279–1290
18. Wahrburg, U.; Kratz, M.; Cullen, P. Mediterranean diet, olive oil and health. Eur. J. Lipid Sci. Technol.2002, 104, 698–705
19. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097
20. Pubmed Website. Available online: http://www.ncbi.nlm.nih.gov/pubmed/ (accessed on 11 March 2015)
21. Lee, C.T.; Rowley, K.; Jenkins, A.J.; O’Dea, K.; Itsiopoulos, C.; Stoney, R.M.; Su, Q.; Giles, G.G.; Best, J.D. Paraoxonase activity in Greek migrants and Anglo-Celtic persons in the Melbourne Collaborative Cohort Study: Relationship to dietary markers. Eur. J. Nutr. 2005, 44, 223–230
22. Blum, S.; Aviram, M.; Ben-Amotz, A.; Levy, Y. Effect of a Mediterranean meal on postprandial carotenoids, paraoxonase activity and C-reactive protein levels. Ann. Nutr. Metab.2006, 50, 20–24
23. Kudchodkar, B.J.; Lacko, A.G.; Dory, L.; Fungwe, T.V. Dietary fat modulates serum paraoxonase 1 activity in rats. J. Nutr.2000, 130, 2427–2433
24. Thomas-Moya, E.; Gianotti, M.; Proenza, A.M.; Llado, I. Paraoxonase 1 response to a high-fat diet: Gender differences in the factors involved. Mol. Med.2007, 13, 203–209
25. Hoefel, A.L.; Hansen, F.; Rosa, P.D.; Assis, A.M.; Silveira, S.L.; Denardin, C.C.; Pettenuzzo, L.; Augusti, P.R.; Somacal, S.; Emanuelli, T.; et al. The effects of hypercaloric diets on glucose homeostasis in the rat: Influence of saturated and monounsaturated dietary lipids. Cell Biochem. Funct.2011, 29, 569–576
26. Tomas, M.; Senti, M.; Elosua, R.; Vila, J.; Sala, J.; Masia, R.; Marrugat, J. Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity. Eur. J. Pharmacol.2001, 432, 121–128
27. Sutherland, W.H.; Walker, R.J.; de Jong, S.A.; van Rij, A.M.; Phillips, V.; Walker, H.L. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat. Arterioscler. Thromb. Vasc. Biol.1999, 19, 1340–1347
28. Lou-Bonafonte, J.M.; Arnal, C.; Navarro, M.A.; Osada, J. Efficacy of bioactive compounds from extra virgin olive oil to modulate atherosclerosis development. Mol. Nutr. Food Res.2012, 56, 1043–1057
29. Perez-Jimenez, F.; Alvarez de Cienfuegos, G.; Badimon, L.; Barja, G.; Battino, M.; Blanco, A.; Bonanome, A.; Colomer, R.; Corella-Piquer, D.; Covas, I.; et al. International conference on the healthy effect of virgin olive oil. Eur. J. Clin. Investig.2005, 35, 421–424
30. Mata, P.; Alvarez-Sala, L.A.; Rubio, M.J.; Nuno, J.; de Oya, M. Effects of long-term monounsaturated- vs. polyunsaturated-enriched diets on lipoproteins in healthy men and women. Am. J. Clin. Nutr.1992, 55, 846–850
31. Stock, J. Importance of HDL functionality to cardiovascular risk. Atherosclerosis2011, 218, 19–20
32. Lou-Bonafonte, J.M.; Fito, M.; Covas, M.I.; Farras, M.; Osada, J. HDL-related mechanisms of olive oil protection in cardiovascular disease. Curr. Vasc. Pharmacol.2012, 10, 392–409
33. Baker, P.W.; Rye, K.A.; Gamble, J.R.; Vadas, M.A.; Barter, P.J. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J. Lipid Res.1999, 40, 345–353
34. Recalde, D.; Ostos, M.A.; Badell, E.; Garcia-Otin, A.L.; Pidoux, J.; Castro, G.; Zakin, M.M.; Scott-Algara, D. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol.2004, 24, 756–761
35. Shih, D.M.; Gu, L.; Xia, Y.R.; Navab, M.; Li, W.F.; Hama, S.; Castellani, L.W.; Furlong, C.E.; Costa, L.G.; Fogelman, A.M.; et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature1998, 394, 284–287
36. Cherki, M.; Derouiche, A.; Drissi, A.; El Messal, M.; Bamou, Y.; Idrissi-Ouadghiri, A.; Khalil, A.; Adlouni, A. Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. Nutr. Metab. Cardiovasc. Dis. 2005, 15, 352–360
37. Manning, P.J.; Jong, S.A.; Ryalls, A.R.; Sutherland, W.H. Paraoxonase 1 activity in chylomicrons and VLDL: The effect of type 2 diabetes and meals rich in saturated fat and oleic acid. Lipids 2012, 47, 259–267
38. Wallace, A.J.; Sutherland, W.H.; Mann, J.I.; Williams, S.M. The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes. Eur. J. Clin. Nutr.2001, 55, 951–958
39. Fuhrman, B.; Volkova, N.; Aviram, M. Postprandial serum triacylglycerols and oxidative stress in mice after consumption of fish oil, soy oil or olive oil: Possible role for paraoxonase-1 triacylglycerol lipase-like activity. Nutrition 2006, 22, 922–930
40. Acin, S.; Navarro, M.A.; Carnicer, R.; Arbones-Mainar, J.M.; Guzman, M.A.; Arnal, C.; Beltran, G.; Uceda, M.; Maeda, N.; Osada, J. Dietary cholesterol suppresses the ability of olive oil to delay the development of atherosclerotic lesions in apolipoprotein E knockout mice. Atherosclerosis2005, 182, 17–28
41. Arbones-Mainar, J.M.; Navarro, M.A.; Carnicer, R.; Guillen, N.; Surra, J.C.; Acin, S.; Guzman, M.A.; Sarria, A.J.; Arnal, C.; Aguilera, M.P.; et al. Accelerated atherosclerosis in apolipoprotein E-deficient mice fed Western diets containing palm oil compared with extra virgin olive oils: A role for small, dense high-density lipoproteins. Atherosclerosis2007, 194, 372–382
42. Graham, A.; Hassall, D.G.; Rafique, S.; Owen, J.S. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis1997, 135, 193–204
43. Valabhji, J.; McColl, A.J.; Schachter, M.; Dhanjil, S.; Richmond, W.; Elkeles, R.S. High-density lipoprotein composition and paraoxonase activity in Type I diabetes. Clin. Sci. (Lond.)2001, 101, 659–670
44. Kontush, A.; Chantepie, S.; Chapman, M.J. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler. Thromb. Vasc. Biol.2003, 23, 1881–1888
45. Efrat, M.; Rosenblat, M.; Mahmood, S.; Vaya, J.; Aviram, M. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: In vitro and in vivo studies. Atherosclerosis2009, 202, 461–469
46. Hussein, O.; Grosovski, M.; Lasri, E.; Svalb, S.; Ravid, U.; Assy, N. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J. Gastroenterol.2007, 13, 361–368
47. Bayram, B.; Ozcelik, B.; Grimm, S.; Roeder, T.; Schrader, C.; Ernst, I.M.; Wagner, A.E.; Grune, T.; Frank, J.; Rimbach, G. A diet rich in olive oil phenolics reduces oxidative stress in the heart of SAMP8 mice by induction of Nrf2-dependent gene expression. Rejuvenation Res. 2012, 15, 71–81
48. Rosenblat, M.; Volkova, N.; Coleman, R.; Almagor, Y.; Aviram, M. Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: Enhanced macrophage cholesterol efflux. J. Nutr. Biochem. 2008, 19, 514–523
49. Acin, S.; Navarro, M.A.; Arbones-Mainar, J.M.; Guillen, N.; Sarria, A.J.; Carnicer, R.; Surra, J.C.; Orman, I.; Segovia, J.C.; Torre, R.; et al. Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient mice. J. Biochem.2006, 140, 383–391
50. Guillen, N.; Acin, S.; Navarro, M.A.; Perona, J.S.; Arbones-Mainar, J.M.; Arnal, C.; Sarria, A.J.; Surra, J.C.; Carnicer, R.; Orman, I.; et al. Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis2008, 197, 72–83
51. Gabas-Rivera, C.; Barranquero, C.; Martinez-Beamonte, R.; Navarro, M.A.; Surra, J.C.; Osada, J. Dietary squalene increases high density lipoprotein-cholesterol and paraoxonase 1 and decreases oxidative stress in mice. PLoS ONE 2014, 9, e104224
52. Arunima, S.; Rajamohan, T. Effect of virgin coconut oil enriched diet on the antioxidant status and paraoxonase 1 activity in ameliorating the oxidative stress in rats–A comparative study. Food Funct. 2013, 4, 1402–1409
53. Boskou, D. Olive Oil, Chemistry and Technology; AOCS Press: Champaign, IL, USA, 1996
54. Civantos, L.; Contreras, R.; Grana, R. Obtención del Aceite de Oliva Virgen, 2nd ed.; Agrícola Española, S.A., Ed.; Editorial Agrícola Española: Madrid, Spain, 1999
55. Harwood, J.; Aparicio, R. Handbook of Olive Oil: Analysis and Properties; Kluwer Academic: Dordrecht, The Netherlands, 2000
56. Jiménez, J.; Rondón, D.; Martínez, L.; Mataix, J. Composición química de los aceites de oliva. In Aceite de Oliva Virgen: Nuestro patrimonio alimentario; Mataix, J., Ed.; Universidad de Granada, Puleva Food: Granada, Spain, 2001; pp. 115–136
57. Montedoro, G.F.; Taticchi, A.; Esposto, S.; Selvaggini, R.; Urbani, S.; Servilli, M. Antioxidants in virgin olive oil. Olea 2007, 26, 5–13
58. Sabate, J.; Wien, M. Nuts, blood lipids and cardiovascular disease. Asia Pac. J. Clin. Nutr.2010, 19, 131–136
59. Fito, M.; Guxens, M.; Corella, D.; Saez, G.; Estruch, R.; de la Torre, R.; Frances, F.; Cabezas, C.; Lopez-Sabater Mdel, C.; Marrugat, J.; et al. Effect of a traditional Mediterranean diet on lipoprotein oxidation: A randomized controlled trial. Arch. Intern. Med.2007, 167, 1195–1203
60. Canales, A.; Benedi, J.; Nus, M.; Librelotto, J.; Sanchez-Montero, J.M.; Sanchez-Muniz, F.J. Effect of walnut-enriched restructured meat in the antioxidant status of overweight/obese senior subjects with at least one extra CHD-risk factor. J. Am. Coll. Nutr.2007, 26, 225–232
61. Nus, M.; Frances, F.; Librelotto, J.; Canales, A.; Corella, D.; Sanchez-Montero, J.M.; Sanchez-Muniz, F.J. Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat. J. Nutr.2007, 137, 1783–1788
62. Canales, A.; Sanchez-Muniz, F.J.; Bastida, S.; Librelotto, J.; Nus, M.; Corella, D.; Guillen, M.; Benedi, J. Effect of walnut-enriched meat on the relationship between VCAM, ICAM, and LTB4 levels and PON-1 activity in ApoA4 360 and PON-1 allele carriers at increased cardiovascular risk. Eur. J. Clin. Nutr.2011, 65, 703–710
63. Sanchez-Muniz, F.J.; Canales, A.; Nus, M.; Bastida, S.; Guillen, M.; Corella, D.; Olmedilla-Alonso, B.; Granado-Lorencio, F.; Benedi, J. The antioxidant status response to low-fat and walnut paste-enriched meat differs in volunteers at high cardiovascular Risk carrying different PON-1 polymorphisms. J. Am. Coll. Nutr.2012, 31, 194–205
64. Strunz, C.C.; Oliveira, T.V.; Vinagre, J.C.; Lima, A.; Cozzolino, S.; Maranhao, R.C. Brazil nut ingestion increased plasma selenium but had minimal effects on lipids, apolipoproteins, and high-density lipoprotein function in human subjects. Nutr. Res.2008, 28, 151–155
65. Aksoy, N.; Aksoy, M.; Bagci, C.; Gergerlioglu, H.S.; Celik, H.; Herken, E.; Yaman, A.; Tarakcioglu, M.; Soydinc, S.; Sari, I.; et al. Pistachio intake increases high density lipoprotein levels and inhibits low-density lipoprotein oxidation in rats. Tohoku J. Exp. Med.2007, 212, 43–48
66. Surra, J.C.; Barranquero, C.; Torcal, M.P.; Orman, I.; Segovia, J.C.; Guillen, N.; Navarro, M.A.; Arnal, C.; Osada, J. In comparison with palm oil, dietary nut supplementation delays the progression of atherosclerotic lesions in female apoE-deficient mice. Br. J. Nutr.2013, 109, 202–209
67. Liu, S.; Manson, J.E.; Lee, I.M.; Cole, S.R.; Hennekens, C.H.; Willett, W.C.; Buring, J.E. Fruit and vegetable intake and risk of cardiovascular disease: The Women’s Health Study. Am. J. Clin. Nutr.2000, 72, 922–928
68. Strandhagen, E.; Hansson, P.O.; Bosaeus, I.; Isaksson, B.; Eriksson, H. High fruit intake may reduce mortality among middle-aged and elderly men. The Study of Men Born in 1913. Eur. J. Clin. Nutr. 2000, 54, 337–341
69. Bazzano, L.A.; He, J.; Ogden, L.G.; Loria, C.M.; Vupputuri, S.; Myers, L.; Whelton, P.K. Fruit and vegetable intake and risk of cardiovascular disease in US adults: The first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am. J. Clin. Nutr.2002, 76, 93–99
70. Daniels, J.A.; Mulligan, C.; McCance, D.; Woodside, J.V.; Patterson, C.; Young, I.S.; McEneny, J. A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes. Cardiovasc. Diabetol.2014, 13, 16
71. Proteggente, A.R.; Pannala, A.S.; Paganga, G.; van Buren, L.; Wagner, E.; Wiseman, S.; van de Put, F.; Dacombe, C.; Rice-Evans, C.A. The antioxidant activity of regularly consumed fruit and vegetables reflects their phenolic and vitamin C composition. Free Radic. Res.2002, 36, 217–233
72. Lixandru, D.; Mohora, M.; Coman, A.; Stoian, I.; van Gils, C.; Aerts, P.; Manuel, Y.K.B. Diet and paraoxonase 1 enzymatic activity in diabetic foot patients from Romania and Belgium: Favorable association of high flavonoid dietary intake with arylesterase activity. Ann. Nutr. Metab.2010, 56, 294–301
73. Freese, R.; Alfthan, G.; Jauhiainen, M.; Basu, S.; Erlund, I.; Salminen, I.; Aro, A.; Mutanen, M. High intakes of vegetables, berries, and apples combined with a high intake of linoleic or oleic acid only slightly affect markers of lipid peroxidation and lipoprotein metabolism in healthy subjects. Am. J. Clin. Nutr.2002, 76, 950–960
74. Rantala, M.; Silaste, M.L.; Tuominen, A.; Kaikkonen, J.; Salonen, J.T.; Alfthan, G.; Aro, A.; Kesaniemi, Y.A. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women. J. Nutr.2002, 132, 3012–3017
75. Rosenblat, M.; Volkova, N.; Aviram, M. Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2. Atherosclerosis2010, 212, 86–92
76. Aviram, M.; Rosenblat, M. Pomegranate for your cardiovascular health. Rambam Maimonides Med. J. 2013, 4, e0013
77. Khateeb, J.; Gantman, A.; Kreitenberg, A.J.; Aviram, M.; Fuhrman, B. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: A role for PPAR-gamma pathway. Atherosclerosis2010, 208, 119–125
78. Kaplan, M.; Hayek, T.; Raz, A.; Coleman, R.; Dornfeld, L.; Vaya, J.; Aviram, M. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J. Nutr.2001, 131, 2082–2089
79. Aviram, M.; Dornfeld, L.; Kaplan, M.; Coleman, R.; Gaitini, D.; Nitecki, S.; Hofman, A.; Rosenblat, M.; Volkova, N.; Presser, D.; et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: Studies in atherosclerotic mice and in humans. Drugs Exp. Clin. Res.2002, 28, 49–62
80. Aviram, M.; Dornfeld, L.; Rosenblat, M.; Volkova, N.; Kaplan, M.; Coleman, R.; Hayek, T.; Presser, D.; Fuhrman, B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: Studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 2000, 71, 1062–1076
81. Rosenblat, M.; Volkova, N.; Attias, J.; Mahamid, R.; Aviram, M. Consumption of polyphenolic-rich beverages (mostly pomegranate and black currant juices) by healthy subjects for a short term increased serum antioxidant status, and the serum’s ability to attenuate macrophage cholesterol accumulation. Food Funct. 2010, 1, 99–109
82. Rosenblat, M.; Hayek, T.; Aviram, M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis2006, 187, 363–371
83. Parsaeyan, N.; Mozaffari-Khosravi, H.; Mozayan, M.R. Effect of pomegranate juice on paraoxonase enzyme activity in patients with type 2 diabetes. J. Diabetes Metab. Disord.2012, 11, 11
84. Rock, W.; Rosenblat, M.; Miller-Lotan, R.; Levy, A.P.; Elias, M.; Aviram, M. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. J. Agric. Food Chem.2008, 56, 8704–8713
85. Fuhrman, B.; Volkova, N.; Aviram, M. Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: Studies in vitro and in diabetic patients. Nutrition2010, 26, 359–366
86. Aviram, M.; Rosenblat, M.; Gaitini, D.; Nitecki, S.; Hoffman, A.; Dornfeld, L.; Volkova, N.; Presser, D.; Attias, J.; Liker, H.; et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr.2004, 23, 423–433
87. Suh, J.H.; Romain, C.; Gonzalez-Barrio, R.; Cristol, J.P.; Teissedre, P.L.; Crozier, A.; Rouanet, J.M. Raspberry juice consumption, oxidative stress and reduction of atherosclerosis risk factors in hypercholesterolemic golden Syrian hamsters. Food Funct. 2011, 2, 400–405
88. Kujawska, M.; Ignatowicz, E.; Ewertowska, M.; Markowski, J.; Jodynis-Liebert, J. Cloudy apple juice protects against chemical-induced oxidative stress in rat. Eur. J. Nutr.2011, 50, 53–60
89. Dalgard, C.; Christiansen, L.; Jonung, T.; Mackness, M.I.; de Maat, M.P.; Horder, M. No influence of increased intake of orange and blackcurrant juices and dietary amounts of vitamin E on paraoxonase-1 activity in patients with peripheral arterial disease. Eur. J. Nutr. 2007, 46, 354–363
90. Bub, A.; Barth, S.W.; Watzl, B.; Briviba, K.; Rechkemmer, G. Paraoxonase 1 Q192R (PON1–192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice. Br. J. Nutr.2005, 93, 291–297
91. McEneny, J.; Wade, L.; Young, I.S.; Masson, L.; Duthie, G.; McGinty, A.; McMaster, C.; Thies, F. Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. J. Nutr. Biochem.2013, 24, 163–168
92. Rock, W.; Rosenblat, M.; Borochov-Neori, H.; Volkova, N.; Judeinstein, S.; Elias, M.; Aviram, M. Effects of date (Phoenix dactylifera L., Medjool or Hallawi Variety) consumption by healthy subjects on serum glucose and lipid levels and on serum oxidative status: A pilot study. J. Agric. Food Chem.2009, 57, 8010–8017
93. Pfeuffer, M.; Fielitz, K.; Laue, C.; Winkler, P.; Rubin, D.; Helwig, U.; Giller, K.; Kammann, J.; Schwedhelm, E.; Boger, R.H.; et al. CLA does not impair endothelial function and decreases body weight as compared with safflower oil in overweight and obese male subjects. J. Am. Coll. Nutr.2011, 30, 19–28
94. Ghorbanihaghjo, A.; Kolahi, S.; Seifirad, S.; Rashtchizadeh, N.; Argani, H.; Hajialilo, M.; Khabazi, A.; Alizadeh, S.; Bahreini, E. Effect of fish oil supplements on serum paraoxonase activity in female patients with rheumatoid arthritis: A double-blind randomized controlled trial. Arch. Iran Med.2012, 15, 549–552
95. Stirban, A.; Nandrean, S.; Gotting, C.; Stratmann, B.; Tschoepe, D. Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus. Horm. Metab. Res.2014, 46, 490–492
96. Boesch-Saadatmandi, C.; Niering, J.; Minihane, A.M.; Wiswedel, I.; Gardeman, A.; Wolffram, S.; Rimbach, G. Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice. Atherosclerosis 2010, 211, 110–113
97. Bokkenheuser, V.D.; Shackleton, C.H.; Winter, J. Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem. J.1987, 248, 953–956
98. Al-Rejaie, S.S.; Aleisa, A.M.; Sayed-Ahmed, M.M.; Al-Shabanah, O.A.; Abuohashish, H.M.; Ahmed, M.M.; Al-Hosaini, K.A.; Hafez, M.M. Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat. BMC Complement. Altern. Med.2013, 13, 136
99. Jaganath, I.B.; Crozier, A. Dietary Flavonoids and Phenolic Compounds. In Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology, Fraga, C.G., Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2010; pp. 1–49
100. Zhu, Y.; Huang, X.; Zhang, Y.; Wang, Y.; Liu, Y.; Sun, R.; Xia, M. Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia. J. Clin. Endocrinol. Metab.2014, 99, 561–569
101. Kaufman, P.B.; Duke, J.A.; Brielmann, H.; Boik, J.; Hoyt, J.E. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: Implications for human nutrition and health. J. Altern. Complement. Med. 1997, 3, 7–12
102. Ustundag, B.; Bahcecioglu, I.H.; Sahin, K.; Duzgun, S.; Koca, S.; Gulcu, F.; Ozercan, I.H. Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model. Dig. Dis. Sci.2007, 52, 2006–2014
103. Mohammadshahi, M.; Haidari, F.; Saei, A.A.; Rashidi, B.; Mahboob, S.; Rashidi, M.R. Soy protein, genistein, and daidzein improve serum paraoxonase activity and lipid profiles in rheumatoid arthritis in rats. J. Med. Food2013, 16, 147–154
104. Schrader, C.; Ernst, I.M.; Sinnecker, H.; Soukup, S.T.; Kulling, S.E.; Rimbach, G. Genistein as a potential inducer of the anti-atherogenic enzyme paraoxonase-1: Studies in cultured hepatocytes in vitro and in rat liver in vivo. J. Cell. Mol. Med.2012, 16, 2331–2341
105. Carrero-Gálvez, M.; García-Barroso, C.; Pérez-Bustamante, J.A. Analysis of polyphenolic compounds of different vinegar samples. Z Lebensm Unters Forsch1994, 199, 29–31
106. Cheng, G.W.; Crisosto, C.H. Browning potential, phenolic composition, and polyphenoloxidase activity of buffer extracts of peach and nectarine skin tissue. J. Am. Soc. Hortic. Sci.1995, 120, 835–838
107. Quinde-Axtell, Z.; Baik, B.K. Phenolic compounds of barley grain and their implication in food product discoloration. J. Agric. Food Chem.2006, 54, 9978–9984
108. Jaiswal, N.; Rizvi, S.I. Onion extract (Allium cepa L.), quercetin and catechin up-regulate paraoxonase 1 activity with concomitant protection against low-density lipoprotein oxidation in male Wistar rats subjected to oxidative stress. J. Sci. Food Agric.2014, 94, 2752–2757
109. Amengual-Cladera, E.; Nadal-Casellas, A.; Gomez-Perez, Y.; Gomila, I.; Prieto, R.M.; Proenza, A.M.; Llado, I. Phytotherapy in a rat model of hyperoxaluria: The antioxidant effects of quercetin involve serum paraoxonase 1 activation. Exp. Biol. Med. (Maywood)2011, 236, 1133–1138
110. Kiyici, A.; Okudan, N.; Gokbel, H.; Belviranli, M. The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats. J. Med. Food2010, 13, 725–728
111. Fuhrman, B.; Aviram, M. Preservation of paraoxonase activity by wine flavonoids: Possible role in protection of LDL from lipid peroxidation. Ann. N. Y. Acad. Sci.2002, 957, 321–324
112. Hayek, T.; Fuhrman, B.; Vaya, J.; Rosenblat, M.; Belinky, P.; Coleman, R.; Elis, A.; Aviram, M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol.1997, 17, 2744–2752
113. Hamelet, J.; Demuth, K.; Dairou, J.; Ledru, A.; Paul, J.L.; Dupret, J.M.; Delabar, J.M.; Rodrigues-Lima, F.; Janel, N. Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice. Biochem. Biophys. Res. Commun.2007, 355, 221–227
114. Jang, E.M.; Choi, M.S.; Jung, U.J.; Kim, M.J.; Kim, H.J.; Jeon, S.M.; Shin, S.K.; Seong, C.N.; Lee, M.K. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism2008, 57, 1576–1583
115. Schrader, C.; Schiborr, C.; Frank, J.; Rimbach, G. Curcumin induces paraoxonase 1 in cultured hepatocytes in vitro but not in mouse liver in vivo. Br. J. Nutr.2011, 105, 167–170
116. Curtin, B.F.; Seetharam, K.I.; Dhoieam, P.; Gordon, R.K.; Doctor, B.P.; Nambiar, M.P. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines. J. Cell. Biochem.2008, 103, 1524–1535
117. Wagner, A.E.; Boesch-Saadatmandi, C.; Breckwoldt, D.; Schrader, C.; Schmelzer, C.; Doring, F.; Hashida, K.; Hori, O.; Matsugo, S.; Rimbach, G. Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes—Role of the redox-regulated transcription factor Nrf2. BMC Complement. Altern. Med.2011, 11, 1
118. Gupta, N.; Kandimalla, R.; Priyanka, K.; Singh, G.; Gill, K.D.; Singh, S. Effect of Resveratrol and Nicotine on PON1 Gene Expression: In Vitro Study. Indian J. Clin. Biochem.2014, 29, 69–73
119. Gouedard, C.; Barouki, R.; Morel, Y. Induction of the paraoxonase-1 gene expression by resveratrol. Arterioscler. Thromb. Vasc. Biol.2004, 24, 2378–2383
120. Guyot, E.; Coumoul, X.; Chasse, J.F.; Khallouki, F.; Savouret, J.F.; Poirot, M.; Barouki, R. Identification of a new stilbene-derived inducer of paraoxonase 1 and ligand of the Aryl hydrocarbon Receptor. Biochem. Pharmacol.2012, 83, 627–632
121. Noll, C.; Hamelet, J.; Ducros, V.; Belin, N.; Paul, J.L.; Delabar, J.M.; Janel, N. Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic mice. Food Chem. Toxicol.2009, 47, 230–236
122. Do, G.M.; Kwon, E.Y.; Kim, H.J.; Jeon, S.M.; Ha, T.Y.; Park, T.; Choi, M.S. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem. Biophys. Res. Commun.2008, 374, 55–59
123. Sarandol, E.; Tas, S.; Dirican, M.; Serdar, Z. Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: Effect of vitamin E supplementation. Cell Biochem. Funct. 2005, 23, 1–8
124. Motta, S.; Letellier, C.; Ropert, M.; Motta, C.; Thiebault, J.J. Protecting effect of vitamin E supplementation on submaximal exercise-induced oxidative stress in sedentary dogs as assessed by erythrocyte membrane fluidity and paraoxonase-1 activity. Vet. J. 2009, 181, 288–295
125. Tsakiris, S.; Karikas, G.A.; Parthimos, T.; Tsakiris, T.; Bakogiannis, C.; Schulpis, K.H. Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals. Eur. J. Clin. Nutr.2009, 63, 215–221
126. Ferretti, G.; Bacchetti, T.; Masciangelo, S.; Pallotta, G. Lipid peroxidation in hemodialysis patients: Effect of vitamin C supplementation. Clin. Biochem.2008, 41, 381–386
127. Gatica, L.V.; Vega, V.A.; Zirulnik, F.; Oliveros, L.B.; Gimenez, M.S. Alterations in the lipid metabolism of rat aorta: Effects of vitamin a deficiency. J. Vasc. Res.2006, 43, 602–610
128. Yamagata, K.; Tanaka, N.; Matsufuji, H.; Chino, M. β-carotene reverses the IL-1 β-mediated reduction in paraoxonase-1 expression via induction of the CaMKKII pathway in human endothelial cells. Microvasc. Res. 2012, 84, 297–305
129. Baralic, I.; Djordjevic, B.; Dikic, N.; Kotur-Stevuljevic, J.; Spasic, S.; Jelic-Ivanovic, Z.; Radivojevic, N.; Andjelkovic, M.; Pejic, S. Effect of astaxanthin supplementation on paraoxonase 1 activities and oxidative stress status in young soccer players. Phytother. Res.2013, 27, 1536–1542
130. Yegin, S.C.; Yur, F.; Ceylan, E. Effect of lycopene application in rats with experimental diabetes using lipoprotein, paraoxonase and cytokines. J. Membr. Biol.2013, 246, 621–626
131. Mackinnon, E.S.; El-Sohemy, A.; Rao, A.V.; Rao, L.G. Paraoxonase 1 polymorphisms 172T-->A and 584A-->G modify the association between serum concentrations of the antioxidant lycopene and bone turnover markers and oxidative stress parameters in women 25–70 years of age. J. Nutrigenet. Nutrigenomics2010, 3, 1–8
132. Ernster, L.; Dallner, G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta1995, 1271, 195–204
133. Kamei, M.; Fujita, T.; Kanbe, T.; Sasaki, K.; Oshiba, K.; Otani, S.; Matsui-Yuasa, I.; Morisawa, S. The distribution and content of ubiquinone in foods. Int. J. Vitam. Nutr. Res.1986, 56, 57–63
134. Mattila, P.; Kumpulainen, J. Coenzymes Q9 and Q10: Contents in foods and dietary intake. J. Food Comp. Anal. 2001, 14, 409–417
135. Weber, C.; Bysted, A.; sHolmer, G. Coenzyme Q10 in the diet—daily intake and relative bioavailability. Mol. Asp. Med.1997, 18, S251–S254
136. Bruge, F.; Bacchetti, T.; Principi, F.; Scarpa, E.S.; Littarru, G.P.; Tiano, L. Olive oil supplemented with Coenzyme Q(10): Effect on plasma and lipoprotein oxidative status. Biofactors2012, 38, 249–256
137. Rana, S.K.; Sanders, T.A. Taurine concentrations in the diet, plasma, urine and breast milk of vegans compared with omnivores. Br. J. Nutr.1986, 56, 17–27
138. Dirican, M.; Tas, S.; Sarandol, E. High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism. Clin. Exp. Pharmacol. Physiol.2007, 34, 833–837
139. Kaur, H.D.; Bansal, M.P. Studies on HDL associated enzymes under experimental hypercholesterolemia: Possible modulation on selenium supplementation. Lipids Health Dis. 2009, 8, 55.